Prognostic and Therapeutic Significance of Carbohydrate Antigen 19-9 as Tumor Marker in Patients with Pancreatic Cancer

Publisher： Karger

E-ISSN： 1423-0232|70|4|255-264

ISSN： 0030-2414

Source： Oncology, Vol.70, Iss.4, 2006-10, pp. : 255-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre‐treatment carbohydrate antigen 19‐9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer

By  

HPB, Vol. 17, Iss. 10, 2015-10 ,pp. : 942-952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy?

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 39-42

Karger

Access to resources Recommend Favorite

Prognostic significance of tumor length in patients receiving esophagectomy for esophageal cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 116, Iss. 8, 2017-12 ,pp. : 1114-1122

John Wiley & Sons Inc

Access to resources Recommend Favorite

Syndecan-1 Expression – A Novel Prognostic Marker in Pancreatic Cancer

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 97-106

Karger

Access to resources Recommend Favorite

An elevated preoperative serum carbohydrate antigen 19‐9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer

By  

COLORECTAL DISEASE, Vol. 17, Iss. 5, 2015-05 ,pp. : 417-425

John Wiley & Sons Inc

Access to resources Recommend Favorite